Principal Street Partners’s Alexion Pharmaceuticals Inc ALXN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q3 | – | Sell |
-7,804
| Closed | -$1.43M | – | 204 |
|
|
2021
Q2 | $1.43M | Sell |
7,804
-10,117
| -56% | -$1.86M | 0.38% | 59 |
|
|
2021
Q1 | $2.74M | Buy |
17,921
+6,678
| +59% | +$1.02M | 0.35% | 55 |
|
|
2020
Q4 | $1.76M | Buy |
11,243
+475
| +4% | +$74.2K | 0.54% | 54 |
|
|
2020
Q3 | $1.23M | Hold |
10,768
| – | – | 0.43% | 63 |
|
|
2020
Q2 | $1.21M | Sell |
10,768
-185
| -2% | -$20.8K | 0.45% | 60 |
|
|
2020
Q1 | $984K | Buy |
10,953
+1,131
| +12% | +$102K | 0.41% | 51 |
|
|
2019
Q4 | $1.06M | Buy |
9,822
+660
| +7% | +$71.4K | 0.24% | 75 |
|
|
2019
Q3 | $897K | Sell |
9,162
-708
| -7% | -$69.3K | 0.22% | 79 |
|
|
2019
Q2 | $1.29M | Buy |
9,870
+4,704
| +91% | +$616K | 0.71% | 54 |
|
|
2019
Q1 | $698K | Buy |
+5,166
| New | +$698K | 0.3% | 44 |
|